These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 29045910)
1. Immunogenicity and protective efficacy of multistage vaccine candidates (Mtb8.4-HspX and HspX-Mtb8.4) against Mycobacterium tuberculosis infection in mice. Liu W; Li J; Niu H; Lin X; Li R; Wang Y; Xin Q; Yu H; Wu Y; Zhu B; Tan J Int Immunopharmacol; 2017 Dec; 53():83-89. PubMed ID: 29045910 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695 [TBL] [Abstract][Full Text] [Related]
3. Subunit vaccine consisting of multi-stage antigens has high protective efficacy against Mycobacterium tuberculosis infection in mice. Xin Q; Niu H; Li Z; Zhang G; Hu L; Wang B; Li J; Yu H; Liu W; Wang Y; Da Z; Li R; Xian Q; Wang Y; Zhang Y; Jing T; Ma X; Zhu B PLoS One; 2013; 8(8):e72745. PubMed ID: 23967337 [TBL] [Abstract][Full Text] [Related]
4. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX. Niu H; Hu L; Li Q; Da Z; Wang B; Tang K; Xin Q; Yu H; Zhang Y; Wang Y; Ma X; Zhu B Vaccine; 2011 Nov; 29(51):9451-8. PubMed ID: 22024175 [TBL] [Abstract][Full Text] [Related]
5. The immunogenicity and protective efficacy of Mtb8.4/hIL-12 chimeric gene vaccine. Li H; Li R; Zhong S; Ren H; Zou Y; Chen X; Shi X; Wang M; Long H; Luo Y Vaccine; 2006 Feb; 24(9):1315-23. PubMed ID: 16219397 [TBL] [Abstract][Full Text] [Related]
6. Multi-Stage Tuberculosis Subunit Vaccine Candidate LT69 Provides High Protection against Mycobacterium tuberculosis Infection in Mice. Niu H; Peng J; Bai C; Liu X; Hu L; Luo Y; Wang B; Zhang Y; Chen J; Yu H; Xian Q; Zhu B PLoS One; 2015; 10(6):e0130641. PubMed ID: 26098302 [TBL] [Abstract][Full Text] [Related]
7. A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice. Liu X; Da Z; Wang Y; Niu H; Li R; Yu H; He S; Guo M; Wang Y; Luo Y; Ma X; Zhu B Vaccine; 2016 Mar; 34(11):1370-8. PubMed ID: 26845736 [TBL] [Abstract][Full Text] [Related]
8. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells. Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536 [TBL] [Abstract][Full Text] [Related]
9. A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA:DDA hybrid nanoparticles stimulates mucosal and systemic immunity. Khademi F; Derakhshan M; Yousefi-Avarvand A; Najafi A; Tafaghodi M Microb Pathog; 2018 Dec; 125():507-513. PubMed ID: 30352265 [TBL] [Abstract][Full Text] [Related]
10. APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice. Soleimanpour S; Farsiani H; Mosavat A; Ghazvini K; Eydgahi MR; Sankian M; Sadeghian H; Meshkat Z; Rezaee SA Appl Microbiol Biotechnol; 2015 Dec; 99(24):10467-80. PubMed ID: 26373723 [TBL] [Abstract][Full Text] [Related]
11. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine. Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592 [TBL] [Abstract][Full Text] [Related]
12. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice. Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of immune response against Mycobacterium tuberculosis HspX antigen by incorporation of combined molecular adjuvant (CASAC). Lew MH; Norazmi MN; Tye GJ Mol Immunol; 2020 Jan; 117():54-64. PubMed ID: 31739193 [TBL] [Abstract][Full Text] [Related]
14. A multistage mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis. Liu X; Peng J; Hu L; Luo Y; Niu H; Bai C; Wang Q; Li F; Yu H; Wang B; Chen H; Guo M; Zhu B Hum Vaccin Immunother; 2016 Jul; 12(7):1670-7. PubMed ID: 26901244 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108 [TBL] [Abstract][Full Text] [Related]
16. CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection. Hu S; Chen H; Ma J; Chen Q; Deng H; Gong F; Huang H; Shi C J Appl Microbiol; 2013 Nov; 115(5):1203-11. PubMed ID: 23902541 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis. Mani R; Gupta M; Malik A; Tandon R; Prasad R; Bhatnagar R; Banerjee N Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30104212 [TBL] [Abstract][Full Text] [Related]
18. [Dimo-thylidioctyl ammonium bromide-BCG polysaccharide nucleic acid adjuvant enhanced the immunogenicity of a Mycobacterium tuberculosis subunit vaccine]. Song NN; Wang BX; Shi DZ; Fu LF; Luo Y; Yu HJ; Han SB; Jiao L; Qie YQ; Wang HH; Zhang Y; Zhu BD Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):513-6. PubMed ID: 19954005 [TBL] [Abstract][Full Text] [Related]
19. Microstructured liposome subunit vaccines reduce lung inflammation and bacterial load after Mycobacterium tuberculosis infection. Trentini MM; de Oliveira FM; Gaeti MP; Batista AC; Lima EM; Kipnis A; Junqueira-Kipnis AP Vaccine; 2014 Jul; 32(34):4324-32. PubMed ID: 24951861 [TBL] [Abstract][Full Text] [Related]
20. Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule. Luo Y; Jiang W; Da Z; Wang B; Hu L; Zhang Y; An R; Yu H; Sun H; Tang K; Tang Z; Wang Y; Jing T; Zhu B Scand J Immunol; 2012 Mar; 75(3):293-300. PubMed ID: 22117839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]